Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany.
J Immunol Res. 2022 Feb 7;2022:4387555. doi: 10.1155/2022/4387555. eCollection 2022.
Human neutrophil antigens (HNAs) can be targeted by HNA-allo antibodies and cause a variety of clinical conditions such as transfusion-related acute lung injury (TRALI) and neonatal alloimmune neutropenia (NAIN). The current study is aimed at identifying the genotype and allele frequencies of HNAs in Iranian blood donors.
A total of 150 blood samples were obtained from healthy blood donors. HNA-1, HNA-3, HNA-4, and HNA-5 were genotyped, using the polymerase chain reaction sequence-specific primer (PCR-SSP) technique. The expression of the HNA-2 antigen on the neutrophil surface was evaluated by flow cytometry.
The allele frequencies of FCGR3B∗1 (encoding HNA-1a), FCGR3B∗2 (encoding HNA-1b), and FCGR3B∗3 (encoding HNA-1c) were 0.34, 0.63, and 0.03, respectively. For HNA-3, the allele frequencies for SLC44A2∗1 (encoding HNA-3a) and SLC44A2∗2 (encoding HNA-3b) were 0.63 and 0.37, respectively. The frequencies of ITGAM∗1 (encoding HNA-4a) and ITGAM∗2 (encoding HNA-4b) alleles were 0.85 and 0.15, respectively. Furthermore, the frequencies of ITGAL∗1 (encoding HNA-5a) and ITGAL∗2 (encoding HNA-5b) alleles were 0.72 and 0.28, respectively. In the studied population, HNA-2 antigen was present on the neutrophil surface in 97.3% of the individuals, while no detectable HNA-2 expression was observed in 2.7% of the individuals. However, no significant difference in HNA-2 expression between different age groups was found.
The present study provides the first report of the HNA allele and genotype frequencies among the Iranian population. All HNAs (HNA-1 to HNA-5) were typed using the PCR-SSP and flow cytometer. In the current cohort study, the determined HNA allele frequencies were similar to the previous reports from British, German, and Danish populations. Considering the presence of different Iranian ethnic groups, further studies with a larger sample size are needed to draw a total picture for HNA allele frequencies.
人类中性粒细胞抗原(HNAs)可被 HNA-allo 抗体靶向,并导致多种临床病症,如输血相关性急性肺损伤(TRALI)和新生儿同种免疫性中性粒细胞减少症(NAIN)。本研究旨在鉴定伊朗献血者的 HNA 基因型和等位基因频率。
从 150 名健康献血者中采集血液样本。采用聚合酶链反应序列特异性引物(PCR-SSP)技术对 HNA-1、HNA-3、HNA-4 和 HNA-5 进行基因分型。通过流式细胞术评估 HNA-2 抗原在中性粒细胞表面的表达。
FCGR3B∗1(编码 HNA-1a)、FCGR3B∗2(编码 HNA-1b)和 FCGR3B∗3(编码 HNA-1c)的等位基因频率分别为 0.34、0.63 和 0.03。对于 HNA-3,SLC44A2∗1(编码 HNA-3a)和 SLC44A2∗2(编码 HNA-3b)的等位基因频率分别为 0.63 和 0.37。ITGAM∗1(编码 HNA-4a)和 ITGAM∗2(编码 HNA-4b)等位基因的频率分别为 0.85 和 0.15。此外,ITGAL∗1(编码 HNA-5a)和 ITGAL∗2(编码 HNA-5b)等位基因的频率分别为 0.72 和 0.28。在所研究的人群中,97.3%的个体的中性粒细胞表面存在 HNA-2 抗原,而 2.7%的个体未检测到 HNA-2 表达。然而,不同年龄组之间 HNA-2 表达无显著差异。
本研究首次报道了伊朗人群的 HNA 等位基因和基因型频率。使用 PCR-SSP 和流式细胞仪对所有 HNA(HNA-1 至 HNA-5)进行了分型。在本队列研究中,确定的 HNA 等位基因频率与英国、德国和丹麦人群的先前报告相似。考虑到伊朗不同的民族群体的存在,需要进一步的研究,扩大样本量,以便全面了解 HNA 等位基因频率。